SOLACE (Strengthening the Screening of Lung Cancer in Europe) is an EU project funded under the EU4Health programme. The aim of the project is to create clear, concise and practical guidelines on implementing a lung cancer screening programme at a national level.  

Lung cancer is the second most diagnosed cancer among males and the third among females in EU Member States and the leading cause of cancer death in both sexes. Several randomised trials from US and Europe have demonstrated the capability of low dose computed tomography (LDCT) to detect lung cancer early and significantly reduce mortality.  

The project will run pilots that will identify and enrol specific populations that are currently underrepresented or at higher risk of lung cancer. This includes women, people living with other diseases, ethnic minorities, people living in geographically remote regions, socially deprived populations and people living in remote areas.  

🧩 Project coordination:  A consortium of 33 partners coordinated by European Institute for Biomedical Imaging Research (EIBIR) 

🔍 What’s the goal?  SOLACE aims to develop, test and disseminate tools to help overcome identified bottlenecks and specifically address the health inequalities in different European countries. It will provide a toolbox for individualised approaches for lung cancer screening on a national or regional level. 

🗓️ Timeline: The project will run between April 2023 and March 2026. 

🤝 Our vital role: We are leading on work package 8 (WP8) – dissemination and outreach activities. Our contribution is to create a strong identity and visibility for the project across Europe and beyond. A comprehensive communication strategy and coherent use of media channels will ensure that key findings and messages from SOLACE are widely disseminated to project stakeholders and the public. 

Among other tasks, WP8 will: 

• Establish and maintain a Stakeholder Advisory Group 
• Ensure that the key findings and messages from SOLACE are disseminated and communicated as well as possible using traditional and novel methods, especially to hard-to-reach populations and those at risk 
• ️Together with European Cancer Organisation (ECO) and all the partners, organise a Cancer Screening and Early Detection Policy Summit. 

Further information: www.solacelung.eu or subscribe to the stakeholder forum for newsletter updates. 

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

This project is co-funded under the EU4Health Programme 2021–2027 under grant agreement no. 101101187